UNSPSC 85782526: Alteration of left lower leg with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to alteration of left lower leg with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0Y0J3KZ

UNSPSC 85782526 Alteration of left lower leg with nonautologous tissue substitute, percutaneous approach is a Commodity code that does not align with recent state and local procurement activity. The code nominally describes a specific surgical procedure involving tissue grafting to the lower leg; however, the six recent opportunities posted under this code classify medical evaluation services, pharmacy benefit management, occupational health surveillance, surgical benefit carve-outs, specialty medical services for detained youth, and temporary health professional staffing—none of which involve lower-leg surgical alteration. The mismatch between the code's procedural scope and the actual work being solicited suggests either systematic misclassification in the source material or that this code does not meaningfully capture state and local purchasing patterns. Absent opportunities that genuinely reflect the code's nominal commodity scope, the code shows no actionable recent activity for firms pursuing orthopedic or wound-closure services.

The six opportunities that appear under this code originate from diverse issuing bodies—city retirement offices (City of Phoenix), municipal human resources departments (City of Long Beach), state transportation agencies (Washington State Department of Transportation), county juvenile justice systems (Harris County), county procurement offices (Collier County), and county health systems (County of Santa Clara)—spanning Arizona, California, Florida, and Washington. None of these solicitations call for surgical intervention, implants, tissue substitutes, or procedural capabilities aligned with the code's descriptor. The code does not support a coherent business-development strategy for vendors in orthopedic surgery, surgical supplies, or reconstructive medicine under this taxonomy assignment.